BioCentury

12:39 AM GMT, Sep 6, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Top Story

Panel backs tobramycin inhalation powder

FDA's Anti-Infective Drugs Advisory Committee voted 13-1 that Novartis AG (NYSE:NVS; SIX:NOVN) demonstrated adequate evidence of

Read the full 161 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.